₨45.00
Yes
Lacosamide
Epilepsy
The precise mechanism by which Lacosamide exerts its antiepileptic effects in humans remains to be fully elucidated. In vitro electrophysiological studies have shown that lacosamide selectively enhances slow inactivation of voltage-gated sodium channels, resulting in stabilization of hyperexcitable neuronal membranes and inhibition of repetitive neuronal firing. Lacosamide binds to collapsin response mediator protein-2 (CRMP-2), a phosphoprotein which is mainly expressed in the nervous system and is involved in neuronal differentiation and control of axonal doutgrowth. The role of CRMP-2 binding in seizure control is unknown.
Partial-Onset Seizures: Lacosamide can be initiated with either oral or intravenous administration. The initial dose should be 50mg twice daily (100mg per day). It can be increased at weekly intervals by 100mg/day given as two divided doses up to the recommended maintenance dose of 200 to 400 mg/day, based on individual patient response and tolerability OR As directed by your physician.
The adverse events most commonly (>1% in the Lacosamide total group and greater than placebo) leading to discontinuation were dizziness, ataxia, vomiting, diplopia, nausea, vertigo, and vision blurred.
Medicines to treat heart problems , carbamazepine, lamotrigine or pregabalin , medicines used to treat certain types of irregular heart beat or heart failure , fluconazole, itraconazole or ketoconazole , ritonavir , clarithromycin or rifampicin , a herbal medicine used to treat mild anxiety and depression called St. John’s wort.
Lacosamide is indicated as a monotherapy in the treatment of partial-onset seizures in patients with epilepsy aged 17 years and older.
Do not take Lacosamide : • If you are allergic to lacosamide, or any of the other ingredients of this medicine . If you are not sure whether you are allergic, please discuss with your doctor. • if you have a certain type of heart beat problem called second- or third-degree AV block.
Antiepileptic drugs (AEDs), including Lacosamide, increase the risk of suicidal thoughts or behavior in patients taking these drugs for any indication. Patients treated with any AED for anyindication should be monitored for the emergence or worsening of depression, suicidal thoughts or behavior and/or any unusual changes in mood or behavior.
Treatment with lacosamide has been associated with dizziness which could increase the occurrence of accidental injury or falls.
Prolongations in PR interval with lacosamide have been observed in clinical studies. Lacosamide should be used with caution in patients with known conduction problems or severe cardiac disease such as a history of myocardial infarction or heart failure.
Lacosamide is not recommended for use in children & adolescents below the age of 16. The safety and effectiveness of Lacosamide in pediatric patients <17 years have not been established.
Always consult your physician before using any medicine.
Store this medicine at room temperature, away from direct light and heat.